top of page

Successful Scientific Engagement Supported by Amplity Insights 

Amplity Insights has contributed numerous analyses to-date, including conference-accepted poster presentations, peer-reviewed journal publications and research led studies examining various scientific theses from physician narratives of real-world patient encounters in the U.S. routine care setting. 

 ONCOLOGY 

DIABETES

Assess the prevalence of unrecorded hypoglycemia events by utilizing transcription data and NLP to uncover undiagnosed cases 

Prevalence of Hypoglycemia in a Medical Transcription Database 

 RARE DISEASE 

Describe demographic, clinical characteristics, and the use of genetic testing and patient support tools/services among RP patients 

Patient Characteristics and Use of Genetic Testing and Support Services in Retinitis Pigmentosa 

Hautamaki, E. Frequency And Nature Of Patient-reported Outcome Conversations Between Physicians And Patients With Cystic Fibrosis.

Understand the patient journey, path to diagnosis, symptom profile, treatment rationale and related demographic factors in ultrarare disease 

Primary Hyperoxaluria Type 1 

Hautamaki, E. Frequency And Nature Of Patient-reported Outcome Conversations Between Physicians And Patients With Cystic Fibrosis.

NEUROLOGY

PULMONOLOGY

Evaluate patient characteristics associated with antiepileptic drug discontinuations and switches among patients with epilepsy

Reasons for Treatment Discontinuation and Switch in Patients With Epilepsy

Better understand patients’ reason(s) for their adherence and non-adherence, and better understand patients’ reason(s) for switching medications

Patient Reported Motivations for Medication Switching and/or Adherence Challenges Among Patients Diagnosed With Multiple Sclerosis

AUTOIMMUNE

Physician Behavior Related to Patients Who Present With Uncontrolled Asthma

Assessing HCP actions when treating patients with uncontrolled moderate-to-severe asthma

A pilot study of patients with Systemic Lupus Erythematosus (SLE) initiated on Belimumab

Feasibility of Use of Medical Transcription Data for Real World Evidence Generation

Describe the frequency and nature of PRO conversations and the modalities utilized to alleviate disease burden

Patient-Reported Outcomes in Cystic Fibrosis

Understand documentation of disease activity and impact, reasons for adherence/non-adherence/switching, and physician treatment recommendations

Evaluation of Disease Activity in Patients Diagnosed With Rheumatoid Arthritis

MENTAL HEALTH

Understanding treatment patterns, disruptions, and potential limitations of tyrosine kinase inhibitors in ROS1+ non-small cell lung cancer patients 

Understanding Reasons for Treatment Disruption of Tyrosine Kinase Inhibitors in NSCLC Patients 

Healthcare resource utilization of United States ROS1+ non-small cell lung cancer patients treated with tyrosine kinase inhibitors 

Healthcare Resource Utilization in NSCLC Patients 

Identify physicians’ documentation of Granulocyte Colony-Stimulating Factor (G-CSF) utilization, with a focus on Filgrastim-sndz 

Uptake of the First U.S. Biosimilar: Filgrastim-sndz Utilization Observed in a Medical Transcription Database 

Assess trends in genomic testing from 2008 to 2017 and understand treatment changes among patients due to testing

Real World Clinicogenomic Evidence Generation for Mental Health Disorders in the United States

Examine the Clinical and Humanistic Burden of Patients With Dravet Syndrome and Lennox-Gastaut Syndrome in the United States 

Understanding the patient impact of DS/LGS

Treatment Patterns of Patients With Dravet Syndrome and Lennox-Gastaut Syndrome

Understanding treatment patterns and reasons for treatment discontinuation and switching

Patient Characteristics and Treatment Patterns in Patients With Chronic Migraine

Understand the patient journey, path to diagnosis, symptom profile, treatment rationale and related demographic factors in ultrarare disease

bottom of page